Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Med Decis Making. 2009 Jul 27;30(1):45–57. doi: 10.1177/0272989X09341588

Table 4.

Table 4a. Associations between subject characteristics (dichotomous) and preferences by site

VA Clinic Subjects University Clinic Subjects

Characteristic Percent Preferring Treatment (N= 45) P value Percent Preferring Treatment (N = 27) P value
Race White 46 (24) 0.9 57 (17) 0.3
Other 48 (21) 71 (10)
Gender* Male - - 50 (12) 0.09
Female 75 (15)
Marital status Married 32 (7) 0.1 55 (6) 0.6
Not married 51 (38) 64 (21)
Education Some college 46 (24) 0.9 64 (7) 0.9
No college 48 (21) 61 (20)
Employment Employed 36 (13) 0.1 56 (10) 0.5
Unemployed 53 (32) 65 (17)
Alcohol abuse Never 52 (15) 0.5 67 (14) 0.5
Ever 45 (30) 56 (13)
Drug abuse Never 33 (4) 0.3 86 (6) 0.1
Ever 49 (41) 57 (21)
Health status Excellent/very good 36 (8) 0.3 50 (4) 0.5
Good/fair/poor 50 (37) 64 (23)
Mental illness No 37 (21) 0.02 71 (20) 0.07
Yes 60 (23) 44 (7)
Degree of fibrosis Mild/none 24 (11) <0.0001 50 (6) 0.4
Moderate 61 (25) 62 (16)
Severe 100 (9) 83 (5)
Genotype 1 45 (35) 0.2 56 (19) 0.08
2 64 (9) 89 (8)
Table 4b. Associations between subject characteristics (continuous) and preferences by site.

Median (range) VA Clinic Subjects Median (range)University Clinic Subjects

Characteristic Preferring treatment (N=45) Not preferring treatment (N=51) P value Preferring treatment (N=27) Not preferring treatment (N=17) P value
Age 53 (39–64) 54 (34–70) 0.9 46 (23–64) 51 (26–69) 0.1
HCV-related quality of life 27 (90–70) 11 (0–80) 0.08 30 (2–77) 18 (0–84) 0.5
Expectation of developing cirrhosis 50 (0–100) 20 (0–85) 0.0002 50 (0–100) 50 (0–100) 0.8
Social support 53 (5–98) 62 (12–99) 0.1 84 (32–100) 67 (29–100) 0.2
Trust in physician 66 (36–75) 64 (45–79) 0.2 66 (48–77) 64 (50–77) 0.7
Decisional conflict 25 (0–50) 33 (90–73) 0.1 29 (0–58) 42 (12–71) 0.03
*

Unable to test the effect of gender at the VA.